Evaluation of non-invasive clinical samples in chronic chlamydial prostatitis by using in situ hybridization

Simple item page
dc.contributor.authorGumus, B
dc.contributor.authorSengil, AZ
dc.contributor.authorSolak, M
dc.contributor.authorFistik, T
dc.contributor.authorAlibey, E
dc.contributor.authorCakmak, EA
dc.contributor.authorYeter, M
dc.date.accessioned2024-07-18T11:49:18Z
dc.date.available2024-07-18T11:49:18Z
dc.description.abstractSeventy-eight non-invasive prostate specimens collected from patients with chronic non-bacterial prostatitis were evaluated by in situ hybridization (IH) for evidence of Chlamydia trachomatis. Intracellular Chlamydia bodies were detected in 18 of 78 cases (20.6%). Homogeneous blue-black bodies in the cellular cytoplasm were accepted as in situ positive. Chlamydial antigen detected by enzyme immune assay (EIA) was positive in 12 cases (13.7%), but only nine of them were positive by IH. Our study confirms previous reports implicating C. trachomatis as an aetiological agent in chronic non-bacterial prostatitis, and underscores the applicability of DNA probes for detection and identification of C. trachomatis in prostatic materials.
dc.identifier.issn0036-5599
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/3931
dc.language.isoEnglish
dc.publisherINFORMA HEALTHCARE
dc.subjectINSITU DNA HYBRIDIZATION
dc.subjectABACTERIAL PROSTATITIS
dc.subjectTRACHOMATIS
dc.subjectDIAGNOSIS
dc.subjectCULTURE
dc.subjectMEN
dc.titleEvaluation of non-invasive clinical samples in chronic chlamydial prostatitis by using in situ hybridization
dc.typeArticle

Files

Collections

Web of Science Koleksiyonu